Scott E. Eggener to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Scott E. Eggener has written about Xenograft Model Antitumor Assays.
Connection Strength
0.033
-
Suppressive roles of calreticulin in prostate cancer growth and metastasis. Am J Pathol. 2009 Aug; 175(2):882-90.
Score: 0.019
-
Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clin Cancer Res. 2005 Jul 01; 11(13):4905-11.
Score: 0.014